loadpatents
Patent applications and USPTO patent grants for Lunardi; Serena.The latest application filed is for "biomarkers for determining responsiveness to lsd1 inhibitors".
Patent | Date |
---|---|
Combinations of LSD1 inhibitors for the treatment of hematological malignancies Grant 11,013,698 - Ciceri , et al. May 25, 2 | 2021-05-25 |
Biomarkers For Determining Responsiveness To Lsd1 Inhibitors App 20190256930 - AREVALO S NCHEZ; Maria Isabel ;   et al. | 2019-08-22 |
Combinations of LSD1 inhibitors for use in the treatment of solid tumors Grant 10,265,279 - Demario , et al. | 2019-04-23 |
Combinations Of Lsd1 Inhibitors For The Treatment Of Hematological Malignancies App 20190083417 - CICERI; Filippo ;   et al. | 2019-03-21 |
Combinations Of Lsd1 Inhibitors For Use In The Treatment Of Solid Tumors App 20170281567 - DEMARIO; Mark D. ;   et al. | 2017-10-05 |
Combinations Of Lsd1 Inhibitors For The Treatment Of Hematological Malignancies App 20170281566 - CICERI; Filippo ;   et al. | 2017-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.